Literature DB >> 4189753

Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis.

J H Langlands.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4189753     DOI： 10.1016/s0140-6736(70)90835-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  A clinical and microbiological study of venous catheterization.

Authors:  J A Smith; A Selick; G Edelist
Journal:  Can Med Assoc J       Date:  1973-07-21       Impact factor: 8.262

3.  Editorial: Treatment of acute exacerbations of chronic bronchitis.

Authors: 
Journal:  Br Med J       Date:  1973-11-24

4.  Neuraminic acid content of sputum in chronic bronchitis.

Authors:  E E Keal; L Reid
Journal:  Thorax       Date:  1972-11       Impact factor: 9.139

5.  Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344].

Authors:  Peter N Black; Althea Morgan-Day; Tracey E McMillan; Phillippa J Poole; Robert P Young
Journal:  BMC Pulm Med       Date:  2004-12-06       Impact factor: 3.317

Review 6.  A reappraisal of the mucoactive activity and clinical efficacy of bromhexine.

Authors:  Alessandro Zanasi; Massimiliano Mazzolini; Ahmad Kantar
Journal:  Multidiscip Respir Med       Date:  2017-03-20

7.  Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.

Authors:  Maurizio Moretti; Stefano Fagnani
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-28

8.  Evaluating the efficacy and safety of bromhexine hydrochloride tablets in treating pediatric COVID-19: A protocol for meta-analysis and systematic review.

Authors:  Yuying Wang; Yinghua Zhang; Xia Chen; Kun Xue; Tianjing Zhang; Xiaohong Ren
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.